Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

From bench to bedside: the realities of reducing global prostate cancer disparity in black men.

Roberts R.

Ecancermedicalscience. 2014 Aug 28;8:458. doi: 10.3332/ecancer.2014.458. eCollection 2014. Review.

PMID:
25228914
[PubMed]
Free PMC Article
2.

Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.

Abrate A, Lughezzani G, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Buffi N, Guazzoni G, Lazzeri M.

Korean J Urol. 2014 Jul;55(7):436-45. doi: 10.4111/kju.2014.55.7.436. Epub 2014 Jul 11.

PMID:
25045441
[PubMed - in process]
Free PMC Article
3.

Current early diagnostic biomarkers of prostate cancer.

Qu M, Ren SC, Sun YH.

Asian J Androl. 2014 Jul-Aug;16(4):549-54. doi: 10.4103/1008-682X.129211.

PMID:
24830695
[PubMed - in process]
Free PMC Article
4.

Morbidity and psychological impact of prostate biopsy: the future calls for a change.

Minervini A, Vittori G, Siena G, Carini M.

Asian J Androl. 2014 May-Jun;16(3):415-7. doi: 10.4103/1008-682X.126388. No abstract available.

PMID:
24713833
[PubMed - in process]
Free PMC Article
5.

Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.

Sapre N, Hong MK, Macintyre G, Lewis H, Kowalczyk A, Costello AJ, Corcoran NM, Hovens CM.

PLoS One. 2014 Apr 4;9(4):e91729. doi: 10.1371/journal.pone.0091729. eCollection 2014.

PMID:
24705338
[PubMed - in process]
Free PMC Article
6.

The Prostate Health Index: a new test for the detection of prostate cancer.

Loeb S, Catalona WJ.

Ther Adv Urol. 2014 Apr;6(2):74-7. doi: 10.1177/1756287213513488. Review.

PMID:
24688603
[PubMed]
Free PMC Article
7.

The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort.

Hirama H, Sugimoto M, Ito K, Shiraishi T, Kakehi Y.

J Cancer Res Clin Oncol. 2014 Feb;140(2):257-63. doi: 10.1007/s00432-013-1566-2. Epub 2013 Dec 19.

PMID:
24352745
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Future prospects in the diagnosis and management of localized prostate cancer.

Tefekli A, Tunc M.

ScientificWorldJournal. 2013 Sep 14;2013:347263. doi: 10.1155/2013/347263. eCollection 2013. Review.

PMID:
24163619
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs.

Jiang H, Liu F, Wang Z, Na R, Zhang L, Wu Y, Zheng J, Lin X, Jiang D, Sun J, Zheng SL, Ding Q, Xu J.

Prostate. 2013 Nov;73(15):1651-9. doi: 10.1002/pros.22661. Epub 2013 Jul 18.

PMID:
23868750
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.

Ferro M, Bruzzese D, PerdonĂ  S, Marino A, Mazzarella C, Perruolo G, D'Esposito V, Cosimato V, Buonerba C, Di Lorenzo G, Musi G, De Cobelli O, Chun FK, Terracciano D.

PLoS One. 2013 Jul 4;8(7):e67687. doi: 10.1371/journal.pone.0067687. Print 2013.

PMID:
23861782
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Personalized management in low-risk prostate cancer: the role of biomarkers.

Dijkstra S, Hamid AR, Leyten GH, Schalken JA.

Prostate Cancer. 2012;2012:327104. doi: 10.1155/2012/327104. Epub 2012 Dec 13.

PMID:
23304520
[PubMed]
Free PMC Article
12.

Genetic association of the KLK4 locus with risk of prostate cancer.

Lose F, Srinivasan S, O'Mara T, Marquart L, Chambers S, Gardiner RA, Aitken JF; Australian Prostate Cancer BioResource, Spurdle AB, Batra J, Clements JA.

PLoS One. 2012;7(9):e44520. Epub 2012 Sep 6.

PMID:
22970239
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.

Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ.

J Urol. 2012 Oct;188(4):1131-6. doi: 10.1016/j.juro.2012.06.009. Epub 2012 Aug 15.

PMID:
22901577
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.

Rhodes T, Jacobson DJ, McGree ME, St Sauver JL, Girman CJ, Lieber MM, Klee GG, Demissie K, Jacobsen SJ.

Urology. 2012 Mar;79(3):655-61. doi: 10.1016/j.urology.2011.09.056.

PMID:
22386420
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.

Carter HB.

Asian J Androl. 2012 May;14(3):355-60. doi: 10.1038/aja.2011.141. Epub 2012 Feb 20. Review.

PMID:
22343493
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Screening for prostate cancer: early detection or overdetection?

Vickers AJ, Roobol MJ, Lilja H.

Annu Rev Med. 2012;63:161-70. doi: 10.1146/annurev-med-050710-134421. Epub 2011 Nov 3. Review.

PMID:
22053739
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk